Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIRTH: Boceprevir in HCV/HIV Coinfection
NCT01482767Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2012
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2012; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01482767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01482767.